<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 11-K
ANNUAL REPORT
PURSUANT TO SECTION 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
FOR THE PLAN YEAR ENDED DECEMBER 31, 1998
PROTEIN TECHNOLOGIES INTERNATIONAL, INC.
SAVINGS INVESTMENT PLAN
(FULL TITLE OF THE PLAN)
PROTEIN TECHNOLOGIES INTERNATIONAL, INC.
1034 DANFORTH DRIVE
ST. LOUIS, MISSOURI 63102
(NAME AND ADDRESS OF PRINCIPAL EXECUTIVE OFFICE OF ISSUER)
================================================================================
<PAGE>
Pursuant to the requirements of the Securities and Exchange Act of 1934, Protein
Technologies International, Inc. has duly caused this Annual Report to be signed
by the undersigned hereunto duly authorized.
Protein Technologies International, Inc
Savings Investment Plan
Date: June 23, 2000
BY /s/ William A. Spenla
----------------------------------------
William A. Spenla, Vice President
Human Resources
<PAGE>
[LOGO OF PRICEWATERHOUSECOOPERS]
PROTEIN
TECHNOLOGIES
INTERNATIONAL
SAVINGS INVESTMENT
PLAN
Financial Statements and
Additional Information
For the Periods
Ended December 31, 1998 and 1997
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Index to Financial Statements and Additional Information
December 31, 1998 and 1997
--------------------------------------------------------------------------------
Page
Report of Independent Accountants 1
Financial Statements:
Statements of Net Assets Available for Benefits
at December 31, 1998 and 1997 2-3
Statements of Changes in Net Assets Available
for Benefits for the Year Ended December 31,
1998 and the Month Ended December 31, 1997 4-5
Notes to Financial Statements 6-9
Additional Information*:
Schedule of Assets Held for Investment Purposes
at December 31, 1997 Schedule I
Schedule of Reportable Transactions for the
Month Ended December 31, 1997 Schedule II
Schedule of Assets Held for Investment Purposes
at December 31, 1998 Schedule III
Schedule of Reportable Transactions for the
Year Ended December 31, 1998 Schedule IV
EXHIBITS
--------
Exhibit
Number Description
------- -----------
24 Consent of
Independent Accountants
* Other schedules required by Section 2520.103-10 of the Department of Labor
Rules and Regulations for Reporting and Disclosure under ERISA have been
omitted because they are not applicable.
<PAGE>
[LETTERHEAD OF PRICEWATERHOUSECOOPERS]
Report of Independent Accountants
September 14, 1999
To the Participants and Plan Administrator
of the Protein Technologies International
Savings Investment Plan
In our opinion, the accompanying statements of net assets available for benefits
with fund information and the related statements of changes in net assets
available for benefits with fund information present fairly, in all material
respects, the net assets available for benefits with fund information of the
Protein Technologies International Savings Investment Plan (the "Plan") at
December 31, 1998 and 1997, and the changes in net assets available for benefits
with fund information for the year ended December 31, 1998 and the month ended
December 31, 1997 in conformity with generally accepted accounting principles.
These financial statements are the responsibility of the Plan's management; our
responsibility is to express an opinion on these financial statements based on
our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.
Our audits were conducted for the purpose of forming an opinion on the basic
financial statements taken as a whole. The supplemental schedules of assets held
for investment purposes and reportable transactions are presented for the
purpose of additional analysis and are not a required part of the basic
financial statements but are supplementary information required by the
Department of Labor's Rules and Regulations for Reporting and Disclosure under
the Employee Retirement Income Security Act of 1974. The fund information in the
statements of net assets available for benefits and the statements of changes in
net assets available for benefits is presented for purposes of additional
analysis rather than to present the net assets available for plan benefits and
changes in net assets available for benefits of each fund. These supplemental
schedules and fund information are the responsibility of the Plan's management.
The supplemental schedules and fund information have been subjected to the
auditing procedures applied in the audits of the basic financial statements and,
in our opinion, are fairly stated in all material respects in relation to the
basic financial statements taken as a whole.
/s/ PRICEWATERHOUSECOOPERS LLP
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Statement of Net Assets Available for Benefits with Fund Information
December 31, 1998
Page 2
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Vanguard
Vanguard Vanguard Federal
Vanguard 500 International Money Vanguard
Explorer Index Growth Market Wellington
Fund Fund Portfolio Fund Fund
<S> <C> <C> <C> <C> <C>
Assets
Investments, at fair value:
Vanguard Explorer Fund* $ 773,934 $ - $ - $ - $ -
Vanguard 500 Index Fund* 9,481,187
Vanguard International Growth Portfolio* 1,323,135
Vanguard Federal Money Market Fund* 9,871,722
Vanguard Wellington Fund* 4,631,709
Vanguard Windsor II Fund*
Vanguard Retirement Savings Trust*
DuPont Stock Fund*
Participant loans - - - - -
------------ ------------- ------------- ------------- -------------
Total investments 773,934 9,481,187 1,323,135 9,871,722 4,631,709
------------ ------------- ------------- ------------- -------------
Net assets available for benefits $ 773,934 $ 9,481,187 $ 1,323,135 $ 9,871,722 $ 4,631,709
------------ ------------- ------------- ------------- -------------
<CAPTION>
Vanguard
Vanguard Retirement Dupont
Windsor II Savings Stock Participant
Fund Trust Fund Loan Total
<S> <C> <C> <C> <C> <C>
Assets
Investments, at fair value:
Vanguard Explorer Fund* $ - $ - $ - $ - $ 773,934
Vanguard 500 Index Fund* 9,481,187
Vanguard International Growth Portfolio* 1,323,135
Vanguard Federal Money Market Fund* 9,871,722
Vanguard Wellington Fund* 4,631,709
Vanguard Windsor II Fund* 6,372,486 6,372,486
Vanguard Retirement Savings Trust* 664,408 664,408
DuPont Stock Fund* 1,938,183 1,938,183
Participant loans - - - 1,268,130 1,268,130
------------- ------------- ------------- ------------ --------------
Total investments 6,372,486 664,408 1,938,183 1,268,130 36,324,894
------------- ------------- ------------- ------------ --------------
Net assets available for benefits $ 6,372,486 $ 664,408 $ 1,938,183 $ 1,268,130 $36,324,894
------------- ------------- ------------- ------------ --------------
</TABLE>
* Represents 5% or more of net assets available for benefits.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Statement of Net Assets Available for Benefits with Fund Information
December 31, 1997
Page 3
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Vanguard
Vanguard Vanguard Federal
Vanguard 500 International Money Vanguard
Explorer Index Growth Market Wellington
Fund Fund Portfolio Fund Fund
<S> <C> <C> <C> <C> <C>
Assets
Investments, at fair value:
Vanguard Explorer Fund $ 4,448 $ - $ - $ - $ -
Vanguard 500 Index Fund 12,870
Vanguard International Growth Portfolio 6,255
Vanguard Federal Money Market Fund* 326,074
Vanguard Wellington Fund 4,882
Vanguard Windsor II Fund - - - - -
-------------- -------------- --------------- --------------- --------------
Total investments 4,448 12,870 6,255 326,074 4,882
-------------- -------------- --------------- --------------- --------------
Net assets available for benefits $ 4,448 $ 12,870 $ 6,255 $ 326,074 $ 4,882
-------------- -------------- --------------- --------------- --------------
<CAPTION>
Vanguard
Windsor II
Fund Total
<S> <C> <C>
Assets
Investments, at fair value:
Vanguard Explorer Fund $ - $ 4,448
Vanguard 500 Index Fund 12,870
Vanguard International Growth Portfolio 6,255
Vanguard Federal Money Market Fund* 326,074
Vanguard Wellington Fund 4,882
Vanguard Windsor II Fund 7,767 7,767
-------------- --------------
Total investments 7,767 362,296
-------------- --------------
Net assets available for benefits $ 7,767 $ 362,296
-------------- --------------
</TABLE>
* Represents 5% or more of net assets available for benefits.
The accompanying notes are an integral part of these financial statements.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Statement of Changes in Net Assets Available for Benefits with Fund Information
For the Year Ended December 31, 1998
Page 4
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Vanguard
Vanguard Vanguard Federal
Vanguard 500 International Money Vanguard
Explorer Index Growth Market Wellington
Fund Fund Portfolio Fund Fund
<S> <C> <C> <C> <C> <C>
Additions to net assets attributed to:
Investment income:
Interest and dividend income $ 6,531 $ 124,526 $ 25,932 $ 421,251 $ 494,038
Net realized and unrealized gain/(loss)
on investments (37,631) 1,101,703 19,558 - (284,739)
---------------- ------------ --------------- -------------- -------------
(31,100) 1,226,229 45,490 421,251 209,299
---------------- ------------ --------------- -------------- -------------
Contributions:
Employer's 54,121 422,415 57,240 1,153,098 169,360
Participant's 1,109,797 7,440,319 1,882,283 12,642,694 3,209,782
---------------- ------------ --------------- -------------- -------------
1,163,918 7,862,734 1,939,523 13,795,792 3,379,142
---------------- ------------ --------------- -------------- -------------
Asset transfer in - - - - -
---------------- ------------ --------------- -------------- -------------
Total additions/(deductions) 1,132,818 9,088,963 1,985,013 14,217,043 3,588,441
---------------- ------------ --------------- -------------- -------------
Deductions:
Benefits paid to participants 32,535 68,273 4,707 896,946 28,625
---------------- ------------ --------------- -------------- -------------
Total deductions 32,535 68,273 4,707 896,946 28,625
---------------- ------------ --------------- -------------- -------------
Net Increase/(Decrease) Prior to Interfund Transfers 1,100,283 9,020,690 1,980,306 13,320,097 3,559,816
Interfund Transfers (330,797) 447,627 (663,426) (3,774,449) 1,067,011
---------------- ------------ --------------- -------------- -------------
Net increase 769,486 9,468,317 1,316,880 9,545,648 4,626,827
Net Assets Available for Plan Benefits,
Beginning of Year 4,448 12,870 6,255 326,074 4,882
---------------- ------------ --------------- -------------- -------------
End of Year $ 773,934 $ 9,481,187 $ 1,323,135 $ 9,871,722 $ 4,631,709
---------------- ------------ --------------- -------------- -------------
<CAPTION>
Vanguard
Vanguard Retirement
Windsor II Savings Dupont Participant
Fund Trust Stock Loan Total
<S> <C> <C> <C> <C> <C>
Additions to net assets attributed to:
Investment income:
Interest and dividend income $ 617,532 $ 17,539 $ 14,262 $ 98,408 $ 1,820,019
Net realized and unrealized gain/(loss)
on investments (304,498) - (401,668) - 92,725
--------------- ------------ ------------ --------------- --------------
313,034 17,539 (387,406) 98,408 1,912,744
--------------- ------------ ------------ --------------- --------------
Contributions:
Employer's 331,239 13,113 97,914 2,298,500
Participant's 5,140,462 214,142 191,508 31,830,987
--------------- ------------ ------------ --------------- --------------
5,471,701 227,255 289,422 - 34,129,487
--------------- ------------ ------------ --------------- --------------
Asset transfer in - - - 1,056,582 1,056,582
--------------- ------------ ------------ --------------- --------------
Total additions/(deductions) 5,784,735 244,794 (97,984) 1,154,990 37,098,813
--------------- ------------ ------------ --------------- --------------
Deductions:
Benefits paid to participants 25,869 98 666 78,496 1,136,215
--------------- ------------ ------------ --------------- --------------
Total deductions 25,869 98 666 78,496 1,136,215
--------------- ------------ ------------ --------------- --------------
Net Increase/(Decrease) Prior to Interfund Transfers 5,758,866 244,696 (98,650) 1,076,494 35,962,598
Interfund Transfers 605,853 419,712 2,036,833 191,636 -
--------------- ------------ ------------ --------------- --------------
Net increase 6,364,719 664,408 1,938,183 1,268,130 35,962,598
Net Assets Available for Plan Benefits,
Beginning of Year 7,767 - - - 362,296
--------------- ------------ ------------ --------------- --------------
End of Year $ 6,372,486 $ 664,408 $ 1,938,183 $ 1,268,130 $ 36,324,894
--------------- ------------ ------------ --------------- --------------
</TABLE>
The accompanying notes are an integral part of these financial statements.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Statement of Changes in Net Assets Available for Benefits with Fund Information
For the Month Ended December 31, 1997
Page 5
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Vanguard
Vanguard Vanguard Federal
Vanguard 500 International Money
Explorer Index Growth Market
Fund Fund Portfolio Fund
<S> <C> <C> <C> <C>
Additions:
Investment income:
Interest and dividend income $ - $ - $ - $ 95
Net unrealized appreciation of investments 29 133 51 -
--------------- --------------- -------------- --------------
29 133 51 95
--------------- --------------- -------------- --------------
Contributions:
Employer's 151,676
Participant's 4,419 12,737 6,204 174,303
--------------- --------------- -------------- --------------
4,419 12,737 6,204 325,979
--------------- --------------- -------------- --------------
Total additions 4,448 12,870 6,255 326,074
Net assets available for plan benefits,
Beginning of month - - - -
--------------- --------------- -------------- --------------
End of month $ 4,448 $ 12,870 $ 6,255 $ 326,074
--------------- --------------- -------------- --------------
<CAPTION>
Vanguard Vanguard
Wellington Windsor II
Fund Fund Total
<S> <C> <C> <C>
Additions:
Investment income:
Interest and dividend income $ - $ - $ 95
Net unrealized appreciation of investments 33 81 327
--------------- -------------- --------------
33 81 422
--------------- -------------- --------------
Contributions:
Employer's 400 152,076
Participant's 4,849 7,286 209,798
--------------- -------------- --------------
4,849 7,686 361,874
--------------- -------------- --------------
Total additions 4,882 7,767 362,296
Net assets available for plan benefits,
Beginning of month - - -
--------------- -------------- --------------
End of month $ 4,882 $ 7,767 $ 362,296
--------------- -------------- --------------
</TABLE>
The accompanying notes are an integral part of these financial statements.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Notes to Financial Statements
December 31, 1998 and 1997
Page 6
--------------------------------------------------------------------------------
1. Description of the Plan
The following description of the Protein Technologies International
(the "Company") Savings Investment Plan (the "Plan") provides only
general information. Participants should refer to the Plan agreement
for a more complete description of the Plan's provisions.
General
The Plan is a defined-contribution plan covering all domestic regular
full-time and part-time sales, administrative and clerical employees,
production, and maintenance employees of the Company. Participants may
contribute to the Plan upon enrollment; however, one year of covered
service is required in order to receive Company matching contributions
(see "Contributions" below). The Plan is subject to the provisions of
the Employee Retirement Income Security Act of 1974 ("ERISA").
This Plan was established pursuant to Ralston Purina's ("Ralston") sale
of Protein Technologies International to E.I. du Pont de Nemours and
Company ("DuPont"). Protein Technologies employees who were previously
participants in the Ralston Purina Savings Investment Plan were given
the option to transfer their Ralston account balances into the Protein
Technologies Plan. Most employees elected to make this transfer in the
first quarter of 1998.
Contributions
Each year, participants may contribute up to 15% of pre-tax annual
compensation, subject to certain limits imposed by the Internal Revenue
Service (IRS), and the Plan terms. Basic contributions not exceeding 6%
of the participant's compensation are matched 100% by the Company after
one year of covered service.
Vesting
Participants are immediately vested in their contributions plus actual
earnings thereon. Vesting in the Company's matching contribution
portion of their accounts plus actual earnings thereon occurs upon the
participant's completion of five years of credited service.
Plan withdrawals
Plan withdrawals of before-tax contributions may be made prior to
termination or retirement for cases of financial hardship or at the age
of 59 1/2 . Hardship distributions are limited to the amount required
to meet the need created by the hardship and are made at the discretion
of the Plan administrator (see "Plan administration" below). After-tax
contributions and earnings thereon may be withdrawn at any time.
Investment options
During the Plan year ended December 31, 1997, participants were able to
allocate their contributions among the following investment options:
Vanguard Explorer Fund: Seeks to provide long-term growth of capital
by investing in a diversified group of small-company stocks with
prospects for above-average growth.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Notes to Financial Statements
December 31, 1998 and 1997
Page 7
--------------------------------------------------------------------------------
Vanguard 500 Index Fund: Seeks to provide long-term growth of capital
and income from dividends by holding all of the 500 stocks that make
up the unmanaged Standard & Poor's 500 Composite Stock Price Index, a
widely recognized benchmark of U.S. stock market performance.
Vanguard International Growth Portfolio: Seeks to provide long-term
growth of capital by investing in stocks of high-quality, seasoned
companies based outside the United States. Stocks are selected from
more than 15 countries.
Vanguard Federal Money Market Fund: Seeks to provide high income and a
stable share price of $1 by investing in short-term securities that
are backed by the full faith and credit of the U.S. government or by
an agency of the government.
Vanguard Wellington Fund: Seeks to provide income and long-term growth
of capital without undue risk to capital by investing about 65% of its
assets in stocks and the remaining 35% in bonds.
Vanguard Windsor II Fund: Seeks to provide long-term growth of capital
and income from dividends by investing in a diversified group of
out-of-favor stocks of large-capitalization companies. The stocks
generally sell at prices below the overall market average compared to
their dividend income and future return potential.
During the Plan year ended December 31, 1998, the following investment
funds were added as investment options:
Vanguard Retirement Savings Trust: Seeks stability of principal and a
high level of current income consistent with a two-to-three year
average maturity. The trust is a tax-exempt collective trust invested
primarily in investment contracts issued by insurance companies and
commercial banks, and similar types of fixed-principal investments.
The trust intends to maintain a constant net asset value of $1.00 per
share.
DuPont Stock Fund: Seeks to provide the potential for long-term growth
through increases in the value of its stock and reinvestment of its
dividends.
Participant loans
Participants may borrow from their fund accounts subject to the
provisions of the Plan. Loans are limited to the lesser of $50,000 or
50% of the vested amount in the participant's account, reduced by
other outstanding participant loan balances on the date of the loan.
The minimum loan amount is $1,000. Participants pay interest on such
loans, at a fixed rate of 1 percentage point above the prime rate on
the date of the loan. Participant loans can be short or long-term, up
to a maximum loan period of 5 years for general purpose loans and 10
years for the purpose of a principal residence. Loan repayments are
made through payroll deduction each pay period. A promissory note in
the amount of the loan must be delivered to the Trustee, and, in the
event of the participant's termination, the unpaid balance and accrued
interest become due immediately and payable in full.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Notes to Financial Statements
December 31, 1998 and 1997
Page 8
--------------------------------------------------------------------------------
Forfeitures
Upon the participant's termination of employment, any Company matching
contributions and the earnings thereon which are not vested will be
forfeited, but will be restored and eligible for additional vesting if
the participant again becomes an eligible employee within five years
after termination and completes the required years of service.
Forfeitures, net of amounts restored, are used to reduce future Company
contributions required under the Plan. Forfeitures were $11,755 and $0
for the year ended December 31, 1998 and the month ended December 31,
1997, respectively.
Plan administration
The Plan is administered by the Company. Vanguard Fiduciary Trust
Company is Trustee of the assets of the Plan. As Trustee, Vanguard has
the authority to hold, manage and protect the assets of the Plan in
accordance with the provisions of the Plan and the trust agreements.
Plan termination
The Company may, by action of its Board of Directors, terminate the
Plan with respect to all participating companies. In case of such
termination, participants shall be fully vested in Company matching
contributions credited to their accounts and, subject to Plan
provisions and applicable law, the total amount in each participant's
account shall be distributed to the participant or for the
participant's benefit.
2. Summary of significant accounting policies
Basis of accounting
The financial statements of the Plan are prepared using the accrual
basis of accounting.
Use of estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets,
liabilities, and changes therein, and disclosure of contingent assets
and liabilities. Actual results could differ from those estimates.
Investment valuation and income recognition
The Plan's investments are stated at fair value. Shares of registered
investment companies are valued at quoted market prices, which
represent the net asset value of shares held by the Plan at year end.
Units of the Retirement Savings Trust are valued at net asset value at
year end. The DuPont Stock Fund is valued at its year-end unit closing
price (comprised of year-end market price plus uninvested cash
position). Participant loans are valued at cost, which approximates
fair value.
Purchases and sales of investments are recorded on a trade-date basis.
Interest income is recorded on the accrual basis. Dividends are
recorded on the ex-dividend date. Capital gain distributions are
included in dividend income.
Investment securities are exposed to various risks, such as interest
rate, market, and credit. Due to the level of risk associated with
certain investment securities and the level of uncertainty related to
changes in the value of investment securities, it is at least
reasonably possible that
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL
SAVINGS INVESTMENT PLAN
Notes to Financial Statements
December 31, 1998 and 1997
Page 9
--------------------------------------------------------------------------------
changes in risks in the near term could materially affect the amounts
reported in the Statement of Net Assets Available for Benefits.
Benefit payments
Benefits are recorded when paid.
3. Related party transactions
DuPont, as the parent company of Protein Technologies International,
the Plan's sponsor, is a related party to the Plan. At December 31,
1998, the Plan held shares of DuPont common stock with a market value
of $1,938,183.
Vanguard Fiduciary Trust Company, as Trustee of the Plan's assets, is a
party-in-interest as defined by ERISA. For Plan assets managed by
Vanguard, the Plan held $33,118,581 and $362,296 of investment funds
and short-term investments at December 31, 1998 and 1997, respectively.
4. Income tax status
The Plan has requested, but has not received a determination letter
from the Internal Revenue Service indicating that the Plan is a
qualified employee benefit plan. The Plan administrator and the Plan's
tax counsel believe that the Plan is designed and is currently being
operated in compliance with the applicable requirements of the Internal
Revenue Code.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL SCHEDULE I
SAVINGS INVESTMENT PLAN
Item 27a Form 5500 - Schedule of Assets Held for Investment Purposes
December 31, 1997
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
(c)
(b) Description of investment including (e)
Identity of issue, borrower, maturity date, rate of interest, (d) Current
(a) lessor or similar party collateral, par, or maturity value Cost value
<S> <C> <C> <C> <C>
* Vanguard Fiduciary Trust Company Explorer Fund $ 4,419 $ 4,448
* Vanguard Fiduciary Trust Company 500 Index Fund 12,737 12,870
* Vanguard Fiduciary Trust Company International Growth Portfolio 6,204 6,255
* Vanguard Fiduciary Trust Company Federal Money Market Fund 326,074 326,074
* Vanguard Fiduciary Trust Company Wellington Fund 4,849 4,882
* Vanguard Fiduciary Trust Company Windsor II Fund 7,686 7,767
--------------- --------------
$ 361,969 $ 362,296
=============== ==============
* Indicates a party-in-interest transaction.
</TABLE>
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL SCHEDULE II
SAVINGS INVESTMENT PLAN
Item 27d Form 5500 - Schedule of Reportable Transactions*
For the Year Ended December 31, 1997
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
(b) (f)
(a) Description of asset (c) (d) (e) Expense
Identity of (include interest rate and Purchase Selling Lease incurred with
party involved maturity in the case of a loan) price price rental transaction
<S> <C> <C> <C> <C> <C>
The Vanguard Group Vanguard Federal Money Market Fund $ 326,074
(h)
(g) Current value (i)
Cost of asset on Net
of asset transaction date gain (loss)
-------------------------------------------
$ 326,074 $ 326,074
</TABLE>
* Transactions or a series of transactions in excess of 5% of the current
value of the Plan's assets as of the beginning of the Plan year as defined
in Section 2520.103-6 of the Department of Labor's Rules and Regulations
for Reporting and Disclosure under ERISA.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL SCHEDULE III
SAVINGS INVESTMENT PLAN
Item 27a Form 5500 - Schedule of Assets Held for Investment Purposes
December 31, 1998
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
(c)
(b) Description of investment including (e)
Identity of issue, borrower, maturity date, rate of interest, (d) Current
(a) lessor or similar party collateral, par, or maturity value Cost value
<S> <S> <S> <C> <C>
* Vanguard Fiduciary Trust Company Explorer Fund $ 775,666 $ 773,934
* Vanguard Fiduciary Trust Company 500 Index Fund 8,415,540 9,481,187
* Vanguard Fiduciary Trust Company International Growth Portfolio 1,289,674 1,323,135
* Vanguard Fiduciary Trust Company Federal Money Market Fund 9,871,722 9,871,722
* Vanguard Fiduciary Trust Company Wellington Fund 4,910,900 4,631,709
* Vanguard Fiduciary Trust Company Windsor II Fund 6,678,422 6,372,486
* Vanguard Fiduciary Trust Company Retirement Savings Trust 664,408 664,408
* E.I. DuPont de Nemours and Company Common stock 2,356,761 1,938,183
Participant Loans Interest rates range from 7% to 11.5%, maturity dates
range from 1999 to 2008 1,268,130 $1,268,130
-------------- ----------------
$36,231,223 $36,324,894
-------------- ----------------
</TABLE>
* Indicates a party-in-interest transaction.
<PAGE>
PROTEIN TECHNOLOGIES INTERNATIONAL SCHEDULE IV
SAVINGS INVESTMENT PLAN
Item 27d Form 5500 - Schedule of Reportable Transactions*
For the Year Ended December 31, 1998
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
(b) (f)
(a) Description of asset (c) (d) (e) Expense
Identity of (include interest rate and Purchase Selling Lease incurred with
party involved maturity in the case of a loan) price price rental transaction
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
The Vanguard Group Vanguard Explorer Fund $1,412,357
$ 605,241
The Vanguard Group Vanguard 500 Index Fund 9,606,653
1,240,040
The Vanguard Group Vanguard International Growth Portfolio 2,855,916
1,558,594
The Vanguard Group Vanguard Federal Money Market 15,367,964
5,822,316
The Vanguard Group Vanguard Wellington Fund 5,648,863
737,298
The Vanguard Group Vanguard Windsor II Fund 7,298,499
629,282
The Vanguard Group Vanguard Retire Savings Trust 668,161
3,755
E.I. DuPont de Nemours and Company DuPont Stock Fund 2,783,011
443,159
</TABLE>
PROTEIN TECHNOLOGIES INTERNATIONAL SCHEDULE IV
SAVINGS INVESTMENT PLAN
Item 27d Form 5500 - Schedule of Reportable Transactions*
For the Year Ended December 31, 1998
--------------------------------------------------------------------------------
(h)
(g) Current value (i)
Cost of asset on Net
of asset transaction date gain (loss)
--------------------------------------------------------
$1,412,357 $1,412,357
641,110 605,241 $ (35,869)
9,606,653 9,606,653
1,203,849 1,240,040 36,191
2,855,916 2,855,916
1,572,667 1,558,594 (14,073)
15,367,964 15,367,964
5,822,316 5,822,316 -
5,648,863 5,648,863
742,811 737,298 (5,513)
7,298,499 7,298,499
627,764 629,282 1,518
668,161 668,161
3,755 3,755 -
2,783,011 2,783,011
426,250 443,159 16,909
* Transactions or a series of transactions in excess of 5% of the current
value of the Plan's assets as of the beginning of the Plan year as defined
in Section 2520.103-6 of the Department of Labor's Rules and Regulations
for Reporting and Disclosure under ERISA.
